How Does Erythromycin Stop Protein Synthesis?
•
4 min read
Over 70 years after its discovery in 1952, erythromycin remains a clinically relevant antibiotic for treating a variety of bacterial infections, including those affecting the respiratory tract, skin, and eyes. The power of this macrolide antibiotic lies in its ability to selectively inhibit bacterial protein synthesis, a crucial process for microbial survival.
